These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1279905)

  • 1. Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain.
    González M; Mateu MG; Martínez MA; Carrillo C; Sobrino F
    Vaccine; 1992; 10(11):731-4. PubMed ID: 1279905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic variation of foot-and-mouth disease virus of serotype C during propagation in the field is mainly restricted to only one structural protein (VP1).
    Sobrino F; Martinez MA; Carrillo C; Beck E
    Virus Res; 1989 Dec; 14(4):273-80. PubMed ID: 2560293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus.
    Martinez MA; Carrillo C; Plana J; Mascarella R; Bergada J; Palma EL; Domingo E; Sobrino F
    Gene; 1988; 62(1):75-84. PubMed ID: 2453395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
    Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL
    J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis.
    Carrillo C; Dopazo J; Moya A; Gonzalez M; Martínez MA; Saiz JC; Sobrino F
    Virus Res; 1990 Jan; 15(1):45-55. PubMed ID: 2156389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
    Brown F
    Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary structure of the gene for protein VP1 from foot-and-mouth disease virus serotype O1 isolated in the USSR].
    Onishchenko AM; Petrov NA; Mamaeva NV; Kalashnikova TI; Grinev AA; Sosnovtsev SV; Degtiarev SKh; Karpyshev NN; Perevozchikova NA; Ivaniushchenkov Vn
    Mol Gen Mikrobiol Virusol; 1990 Apr; (4):22-5. PubMed ID: 1694961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization.
    Shieh JJ; Liang CM; Chen CY; Lee F; Jong MH; Lai SS; Liang SM
    Vaccine; 2001 Jul; 19(28-29):4002-10. PubMed ID: 11427276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VP1 of foot-and-mouth disease virus.
    Martín MJ; Núñez JI; Sobrino F; Dopazo J
    J Virol Methods; 1998 Oct; 74(2):215-21. PubMed ID: 9779622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates).
    Tulasiram P; Suryanarayana V
    Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptides as potential vaccines against foot-and-mouth disease.
    Brown F
    Endeavour; 1990; 14(2):87-94. PubMed ID: 1697533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
    J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.
    Saiz JC; Gonzalez MJ; Borca MV; Sobrino F; Moore DM
    J Virol; 1991 May; 65(5):2518-24. PubMed ID: 1707983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.
    Krebs O; Ahl R; Straub OC; Marquardt O
    Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of virus neutralizing epitopes on naturally occurring variants of type A12 foot-and-mouth disease virus.
    Moore DM; Vakharia VN; Morgan DO
    Virus Res; 1989 Dec; 14(4):281-95. PubMed ID: 2483013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
    Kit S; Kit M; DiMarchi RD; Little SP; Gale C
    Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants.
    Carrillo C; Wigdorovitz A; Oliveros JC; Zamorano PI; Sadir AM; Gómez N; Salinas J; Escribano JM; Borca MV
    J Virol; 1998 Feb; 72(2):1688-90. PubMed ID: 9445079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic variation among foot-and-mouth disease virus type A field isolates of 1997-1999 from Iran.
    Marquardt O; Freiberg B
    Vet Microbiol; 2000 Jun; 74(4):377-86. PubMed ID: 10831859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72.
    Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD
    Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.